Michael Thomas Henderson, CEO: Apogee Therapeutics APGE Sell · Filed 01/16

Trade details

Type: Insider sale
Amount: $676,554.32
Shares · price: 8,476 sh · $79.82 a share
Held after: 1,203,071 sh
Stock: Apogee Therapeutics APGE
Person: Michael Thomas HendersonCEO
Trade date: 26/01/14
Filed: 26/01/16
Days to filing: 2 days

Sold 0.7% of holdings

Share of holding sold: 0.7%

Apogee Therapeutics trades, last 26 weeks

What else happened in Apogee Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/15~02/13

Michael Thomas Henderson's recent trades

Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$10.6M
80,000 sh
$10.6M
Filed 06/24
Traded 06/22
Michael Thomas HendersonDirector
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$2M
20,000 sh
$2M
Filed 06/23
Traded 06/22
Michael Thomas HendersonDirector
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 plan
Spyre Therapeutics
SYRE
$1.8M
20,000 sh
$1.8M
Filed 06/22
Traded 06/22
Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$633.6K
7,654 sh
$633.6K
Filed 06/12
Traded 06/10
Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$556.6K
6,770 sh
$556.6K
Filed 06/12
Traded 06/10

Michael Thomas Henderson, CEO — sold $676.6K of Apogee Therapeutics APGE · 0.7% of holdings · 10b5-1 plan | Whalegun